Literature DB >> 2873592

5-HT and anxiety: promises and pitfalls.

A L Johnston, S E File.   

Abstract

This review examines the evidence implicating serotonergic systems in the control of anxiety. The effects of manipulations of 5-HT, including 5-HT lesions, pharmacological reduction and enhancement of serotonergic function in animal tests of anxiety are reviewed. Biochemical and behavioral evidence implicating serotonergic pathways in the anxiolytic action of benzodiazepines is presented. In each section the promises of a serotonergic involvement, as indicated by positive findings, and the pitfalls, evidenced by inconsistent and conflicting results, are discussed. Finally the dangers of a superficial interpretation of the behavioral and biochemical findings is stressed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2873592     DOI: 10.1016/0091-3057(86)90213-3

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  11 in total

Review 1.  5-HT1A partial agonists. What is their future?

Authors:  D A Glitz; R Pohl
Journal:  Drugs       Date:  1991-01       Impact factor: 9.546

2.  Estrogen decreases 5-HT1B autoreceptor mRNA in selective subregion of rat dorsal raphe nucleus: inverse association between gene expression and anxiety behavior in the open field.

Authors:  R Hiroi; J F Neumaier
Journal:  Neuroscience       Date:  2008-11-01       Impact factor: 3.590

3.  Evidence for the involvement of the 5-HT1A receptor in the anxiolytic action of indorenate and ipsapirone.

Authors:  A Fernández-Guasti; C López-Rubalcava
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

Review 4.  Molecular pathways of anxiety revealed by knockout mice.

Authors:  S J Wood; M Toth
Journal:  Mol Neurobiol       Date:  2001 Apr-Jun       Impact factor: 5.590

5.  Chronic diazepam treatment in rats causes long-lasting changes in central [3H]-5-hydroxytryptamine and [14C]-gamma-aminobutyric acid release.

Authors:  P K Hitchcott; S E File; M Ekwuru; M J Neal
Journal:  Br J Pharmacol       Date:  1990-01       Impact factor: 8.739

6.  Evidence for differential effects of 8-OH-DPAT on male and female rats in the Anxiety/Defense Test Battery.

Authors:  D C Blanchard; J K Shepherd; R J Rodgers; R J Blanchard
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

7.  Social instability in female rats: effects on anxiety and buspirone efficacy.

Authors:  József Haller; Johanna Baranyi; Nikoletta Bakos; József Halász
Journal:  Psychopharmacology (Berl)       Date:  2004-07       Impact factor: 4.530

8.  Characterization of MDL 73005EF as a 5-HT1A selective ligand and its effects in animal models of anxiety: comparison with buspirone, 8-OH-DPAT and diazepam.

Authors:  P C Moser; M D Tricklebank; D N Middlemiss; A K Mir; M F Hibert; J R Fozard
Journal:  Br J Pharmacol       Date:  1990-02       Impact factor: 8.739

9.  Effects in the X-maze anxiety model of agents acting at 5-HT1 and 5-HT2 receptors.

Authors:  M A Critchley; S L Handley
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

10.  Neurochemical and behavioural studies with RU-24969 in the rat.

Authors:  M Carli; R Invernizzi; L Cervo; R Samanin
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.